86% of leukaemia (CML) patients rate their care as ‘excellent’ or ‘very good’. Patient experience varies with individual needs and concerns, which are influenced by many aspects of personal background, disease characteristics and the care environment.
77% of patients were given the name of a Clinical Nurse Specialist in charge of their care. Being given the name of a Clinical Nurse Specialist in charge of a patients’ care is the factor most likely to be associated with high patient satisfaction scores.
64% said they saw their GP once or twice before being told they had to go to hospital. How often a patient sees their GP before being referred to hospital varies by cancer type depending on ease of diagnosis.
For leukaemia (CML) the proportion that said they saw their GP once or twice before being told they had to go to hospital is similar to the average for all cancer patients.
Spotting cancer early is important for improving survival so it is important that patients with potential cancer symptoms are referred for tests promptly.
Chronic Myeloid Leukaemia (C92.1), Patient Experience Survey, by Sex, England, 2014
|Percentage of patients treated for cancer who visited their GP once or twice about the health problem caused by their cancer||57.6%||69.8%||64.4%|
|Percentage of patients treated for cancer who said they were given the name of a Clinical Nurse Specialist in charge of their care||76.1%||77.6%||76.9%|
|Percentage of patients treated for cancer who rated their overall care as excellent or very good||82.6%||87.9%||85.6%|
- Department of Health. Cancer Patient Experience Survey 2014. Accessed October 2015.
- Department of Health. National Cancer Patient Experience Survey Programme: 2010 National Survey Report. Accessed October 2015.
- Lyratzopoulos G1, Neal RD, Barbiere JM et al. Variation in number of general practitioner consultations before hospital referral for cancer: findings from the 2010 National Cancer Patient Experience Survey in England. Lancet Oncol 2012;13(4):353-65.
About this data
Data is for: England, 2014, ICD-10 C92.1
Patient Experience data is for adult patients in England with a primary diagnosis of cancer and who had been in active treatment between September and November 2013 who completed a survey in 2014.